Literature DB >> 17175165

Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.

Courtney Thaxton1, Jorge Lopera, Marga Bott, M Elizabeth Baldwin, Poonam Kalidas, Cristina Fernandez-Valle.   

Abstract

Mutations in the Neurofibromatosis type 2 tumor suppressor gene that encodes Schwannomin causes formation of benign schwannomas. Schwannoma cells lose their characteristic bipolar shape and become rounded with excessive ruffling membranes. Schwannomin is phosphorylated at serine 518 (S518) by p21 activated kinase (Pak). Unphosphorylated schwannomin is associated with growth inhibition but little is known about the function of the phosphorylated form, or the molecular events leading to its phosphorylation. Here, we report in SCs that schwannomin S518 phosphorylation requires binding to paxillin and targeting to the plasma membrane. Phospho-S518-schwannomin is enriched in the peripheral-most aspects of membrane specializations where paxillin, activated Pak, Cdc42 but not Rac are highly expressed. Schwannomin and Pak phosphorylation levels are not reduced in response to lowering Rac-GTP levels with NSC23766. Expression of schwannomin S518A/D-GFP variants each distinctively altered Schwann cell shape and polarity. These results are consistent with tight spatial regulation of S518 phosphorylation at the plasma membrane in a paxillin and Cdc42-Pak dependent manner that leads to local reorganization of the SC cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175165     DOI: 10.1016/j.mcn.2006.11.003

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  15 in total

1.  Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.

Authors:  Courtney Thaxton; Marga Bott; Barbara Walker; Nicklaus A Sparrow; Stephen Lambert; Cristina Fernandez-Valle
Journal:  Mol Cell Neurosci       Date:  2010-12-21       Impact factor: 4.314

2.  Laminin is required for Schwann cell morphogenesis.

Authors:  Wei-Ming Yu; Zu-Lin Chen; Alison J North; Sidney Strickland
Journal:  J Cell Sci       Date:  2009-04-01       Impact factor: 5.285

3.  Cdc42 regulates Schwann cell radial sorting and myelin sheath folding through NF2/merlin-dependent and independent signaling.

Authors:  Li Guo; Chandra Moon; Yi Zheng; Nancy Ratner
Journal:  Glia       Date:  2013-09-06       Impact factor: 7.452

Review 4.  On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.

Authors:  Yue Shao; Jianming Sang; Jianping Fu
Journal:  Biomaterials       Date:  2015-02-21       Impact factor: 12.479

5.  Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.

Authors:  Iram Ahmad; Augusta Fernando; Richard Gurgel; J Jason Clark; Linjing Xu; Marlan R Hansen
Journal:  Neurobiol Dis       Date:  2015-06-06       Impact factor: 5.996

6.  Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation.

Authors:  Christopher S Rex; Lulu Y Chen; Anupam Sharma; Jihua Liu; Alex H Babayan; Christine M Gall; Gary Lynch
Journal:  J Cell Biol       Date:  2009-07-13       Impact factor: 10.539

7.  PAK kinase regulates Rac GTPase and is a potential target in human schwannomas.

Authors:  Christine Flaiz; Jonathan Chernoff; Sylwia Ammoun; Jeffrey R Peterson; Clemens O Hanemann
Journal:  Exp Neurol       Date:  2009-05-03       Impact factor: 5.330

8.  Cytoskeletal changes underlie estrogen's acute effects on synaptic transmission and plasticity.

Authors:  Enikö A Kramár; Lulu Y Chen; Nicholas J Brandon; Christopher S Rex; Feng Liu; Christine M Gall; Gary Lynch
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

9.  Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in glucose-stimulated insulin secretion in pancreatic beta-cells.

Authors:  Rajakrishnan Veluthakal; Suresh Vasu Madathilparambil; Phillip McDonald; Lawrence Karl Olson; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2008-09-27       Impact factor: 5.858

Review 10.  Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.

Authors:  Sarah Beltrami; Richard Kim; Jennifer Gordon
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.